JP2003219893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003219893A5 JP2003219893A5 JP2002337903A JP2002337903A JP2003219893A5 JP 2003219893 A5 JP2003219893 A5 JP 2003219893A5 JP 2002337903 A JP2002337903 A JP 2002337903A JP 2002337903 A JP2002337903 A JP 2002337903A JP 2003219893 A5 JP2003219893 A5 JP 2003219893A5
- Authority
- JP
- Japan
- Prior art keywords
- double
- stranded polynucleotide
- rna
- dna
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002337903A JP3803318B2 (ja) | 2001-11-21 | 2002-11-21 | 遺伝子発現阻害方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-355896 | 2001-11-21 | ||
| JP2001355896 | 2001-11-21 | ||
| JP2002337903A JP3803318B2 (ja) | 2001-11-21 | 2002-11-21 | 遺伝子発現阻害方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003219893A JP2003219893A (ja) | 2003-08-05 |
| JP2003219893A5 true JP2003219893A5 (enExample) | 2006-03-02 |
| JP3803318B2 JP3803318B2 (ja) | 2006-08-02 |
Family
ID=27759143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002337903A Expired - Lifetime JP3803318B2 (ja) | 2001-11-21 | 2002-11-21 | 遺伝子発現阻害方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3803318B2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4843778B2 (ja) * | 2003-10-08 | 2011-12-21 | 独立行政法人産業技術総合研究所 | ｓｉＲＮＡのＲＮＡｉ効果算出装置 |
| US20120269886A1 (en) | 2004-12-22 | 2012-10-25 | Nitto Denko Corporation | Therapeutic agent for pulmonary fibrosis |
| SI2730277T1 (sl) | 2004-12-22 | 2020-07-31 | Nitto Denko Corporation | Nosilec zdravila in komplet za nosilec zdravila za zaviranje fibroze |
| JP2009221164A (ja) | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| US9572886B2 (en) | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
| TWI407971B (zh) | 2007-03-30 | 2013-09-11 | Nitto Denko Corp | Cancer cells and tumor-related fibroblasts |
| WO2008139938A1 (ja) * | 2007-05-02 | 2008-11-20 | National University Corporation Tokyo Medical And Dental University | ヒトパピローマウイルス１６型遺伝子を標的とする二本鎖核酸分子及びそれを含む医薬 |
| WO2008156172A1 (ja) * | 2007-06-20 | 2008-12-24 | Saitama Medical University | 子宮癌、乳癌、及び膀胱癌の予防乃至治療に好適な二本鎖核酸分子、癌細胞増殖抑制剤、並びに医薬 |
| US20110158908A1 (en) | 2007-08-24 | 2011-06-30 | Sapporo Medical University | Cyclosporin a-binding protein |
| TWI455944B (zh) | 2008-07-01 | 2014-10-11 | Daiichi Sankyo Co Ltd | 雙股多核苷酸 |
| JP5950428B2 (ja) | 2010-08-05 | 2016-07-13 | 日東電工株式会社 | 線維化組織から正常組織を再生するための組成物 |
| JP6023709B2 (ja) | 2011-06-21 | 2016-11-09 | 日東電工株式会社 | アポトーシス誘導剤 |
| JP6002382B2 (ja) * | 2011-12-07 | 2016-10-05 | 株式会社バイオシンクタンク | 遺伝子発現阻害剤及び阻害方法 |
| JP6340162B2 (ja) | 2012-12-20 | 2018-06-06 | 日東電工株式会社 | アポトーシス誘導剤 |
| JP6076076B2 (ja) | 2012-12-21 | 2017-02-08 | 日東電工株式会社 | 組織再生促進剤 |
| JP6602034B2 (ja) | 2014-04-02 | 2019-11-06 | 日東電工株式会社 | 標的化分子およびその使用 |
| WO2015155810A1 (en) | 2014-04-07 | 2015-10-15 | Nitto Denko Corporation | Novel polymer-based hydrotropes for hydrophobic drug delivery |
| CN106573062B (zh) | 2014-06-17 | 2020-08-25 | 日东电工株式会社 | 细胞凋亡诱导剂 |
| KR102740699B1 (ko) | 2015-12-13 | 2024-12-09 | 닛토덴코 가부시키가이샤 | 높은 활성 및 감소한 오프 타겟을 위한 sirna 구조 |
-
2002
- 2002-11-21 JP JP2002337903A patent/JP3803318B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003219893A5 (enExample) | ||
| JP2003520811A5 (enExample) | ||
| IL166546A (en) | Double-stranded ribonucleic acid, preparations containing it, is used in drug preparation and in vitro method to inhibit the expression of a target gene | |
| WO2004042029A3 (en) | Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use | |
| WO2003051901A3 (en) | Pseudonucleotide comprising an intercalator | |
| WO2005014782A3 (en) | Double-stranded ribonucleic acid with increased effectiveness in an organism | |
| WO2003012052A3 (en) | Specific inhibition of gene expression by small double stranded rnas | |
| ZA200304500B (en) | Method for inhibiting the expression of a target gene and medicament for treating a tumor disease. | |
| EP2631292A3 (en) | Human microRNAs and methods for inhibiting same | |
| CA2565103C (en) | Peptide conjugated, inosine-substituted antisense oligomer compound and method | |
| WO2002026967A3 (en) | Targeted gene correction by single-stranded oligodeoxynucleotides | |
| JP2015142558A5 (enExample) | ||
| ATE328075T1 (de) | Verfahren zur hemmung der expression eine zielgens | |
| WO2003064625A3 (en) | Oligonucleotide compositions with enhanced efficiency | |
| EP1544297A3 (en) | Medicament for treatment of Duchenne muscular dystrophy | |
| JP2009524419A5 (enExample) | ||
| DE69838449D1 (de) | Aminooxy-modifizierte oligonukleotide | |
| JP2006526394A5 (enExample) | ||
| DE69934227D1 (de) | Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide | |
| WO2007031319A8 (en) | Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides | |
| EP2062586A3 (en) | Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors | |
| WO2004078941A3 (en) | Modulation of gene expression using dna-rna hybrids | |
| WO2004044134A3 (en) | Phosphorous-linked oligomeric compounds and their use in gene modulation | |
| EP3040423A3 (en) | Microrna and uses thereof | |
| JP2006523103A5 (enExample) |